BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.030
+0.020 (1.00%)
Oct 27, 2026, 4:00 PM EDT - Market closed
BioLineRx Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, BioLineRx stock has an average price target of $22. The average 1-year stock price forecast is 983.74% higher than the current stock price, while the lowest is $18 (+786.70%) and the highest is $26 (+1,180.79%).
Price Target: $22 (+983.74%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for BioLineRx is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 0 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $26 | Buy | Maintains | $26 | +1,180.79% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
1.62M
from 1.18M
Increased by 37.33%
Revenue Next Year
2.22M
from 1.62M
Increased by 37.06%
EPS This Year
n/a
from -0.00
EPS Next Year
n/a